Target intelligence / Profile preview

Gut microbiota ecosystem (Clostridioides difficile colonization resistance)

Molecular classification
Other
01

Overview

The gut microbiota ecosystem represents the diverse community of microorganisms in the human intestine that maintains a state of colonization resistance against opportunistic pathogens (Buffie et al., 2015, Nature). In healthy individuals, commensal bacteria prevent the expansion of Clostridioides difficile by competing for limited nutrients and converting primary bile acids into secondary bile acids, which inhibit C. difficile spore germination and vegetative growth (Sorg & Sonenshein, 2008, Journal of Bacteriology). When antibiotics disrupt this ecological balance, a state of dysbiosis occurs, allowing C. difficile to proliferate and produce toxins (TcdA and TcdB) that cause mucosal inflammation and diarrhea (CDC, 2023). Therapeutic strategies like Fecal Microbiota Transplantation (FMT) and FDA-approved live biotherapeutic products, such as Vowst and Rebyota, aim to restore the microbial diversity and metabolic functions of the ecosystem (FDA, 2023). These interventions re-establish the inhibitory environment, effectively preventing recurrent infections by filling the vacant ecological niches and restoring metabolic signaling (Khanna et al., 2022, JAMA).

Other names
Gut microbiomeIntestinal floraColonization resistanceC. difficile colonization
02

Mechanism of action

Restoration of colonization resistance through competitive exclusion, nutrient competition, and production of inhibitory metabolites like secondary bile acids.

03

Biological functions

Colonization resistanceMetabolic homeostasisImmune response
04

Disease associations

InfectionInflammation
05

Safety considerations

Transmission of infectious agentsBacteremiaLong-term microbiome alteration
06

Interacting drugs

Fecal microbiota spores, live-brpk

4 more in the full profile.

07

Biomarkers

Microbial diversity indexSecondary bile acid concentrationClostridioides difficile toxin A/B

Beyond the preview

Go deeper on Gut microbiota ecosystem (Clostridioides difficile colonization resistance).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut microbiota ecosystem (Clostridioides difficile colonization resistance).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call